BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4151332)

  • 21. Raynaud's phenomenon of fingers and toes among vibration-exposed patients.
    Toibana N; Ishikawa N; Sakakibara H; Yamada S
    Nagoya J Med Sci; 1994 May; 57 Suppl():121-8. PubMed ID: 7708094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Digital blood flow and nailfold capillary microscopy in Raynaud's phenomenon.
    Lee P; Sarkozi J; Bookman AA; Keystone EC; Armstrong SK
    J Rheumatol; 1986 Jun; 13(3):564-9. PubMed ID: 3735278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adrenoceptors in Raynaud's disease.
    Lindblad LE; Ekenvall L; Etzell BM; Bevegård S
    J Cardiovasc Pharmacol; 1989 Dec; 14(6):881-5. PubMed ID: 2481777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of Raynaud's syndrome with adrenergic alpha-blockade with or without beta-blockade.
    Cleophas TJ; van Lier HJ; Fennis JF; van 't Laar A
    Angiology; 1984 Jan; 35(1):29-37. PubMed ID: 6141750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between distal blood flow and blood pressure after abolition of the sympathetic vasomotor tone.
    Uhrenholdt A
    Scand J Clin Lab Invest Suppl; 1973; 128():63-5. PubMed ID: 4764600
    [No Abstract]   [Full Text] [Related]  

  • 26. The acute effects of cigarette smoking on cutaneous blood flow in smoking and non-smoking subjects with and without Raynaud's phenomenon.
    Goodfield MJ; Hume A; Rowell NR
    Br J Rheumatol; 1990 Apr; 29(2):89-91. PubMed ID: 2182173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of intra-arterial reserpine in patients suffering from Raynaud's phenomenon.
    Acevedo A; Reginato AJ; Schnell AM
    J Cardiovasc Surg (Torino); 1978; 19(1):77-84. PubMed ID: 627597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The peripheral vascular effects of nifedipine in Raynaud's syndrome associated with scleroderma: a double blind crossover study.
    Finch MB; Dawson J; Johnston GD
    Clin Rheumatol; 1986 Dec; 5(4):493-8. PubMed ID: 3816096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Alpha-adrenoceptor inhibition from indoramin in man.
    Boakes AJ; Prichard BN; Teoh PC
    Br J Pharmacol; 1972 Feb; 44(2):378P-379P. PubMed ID: 4148923
    [No Abstract]   [Full Text] [Related]  

  • 30. Topical nitroglycerin ointment in Raynaud's phenomenon.
    Fischer M; Reinhold B; Falck H; Török M; Alexander K
    Z Kardiol; 1985 May; 74(5):298-302. PubMed ID: 3925656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thermography in evaluating therapy in Raynaud's disease].
    Litmanovitch J; Shilo R; Chayen M
    Harefuah; 1972 Jun; 82(11):503-6. PubMed ID: 5068900
    [No Abstract]   [Full Text] [Related]  

  • 32. Dose-response study of prazosin in Raynaud's phenomenon: clinical effectiveness versus side effects.
    Wollersheim H; Thien T
    J Clin Pharmacol; 1988 Dec; 28(12):1089-93. PubMed ID: 3243924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The neurovascular plexus of the fingers in Buerger's disease, in Raynaud's disease and in scleroderma].
    CURRI SB
    Riv Anat Patol Oncol; 1961 Jun; 19():635-54. PubMed ID: 13882722
    [No Abstract]   [Full Text] [Related]  

  • 34. [Etiologic diversity of digital arteritis].
    Langeron P; Mikati A; Redgosz R
    Phlebologie; 1987; 40(1):11-20. PubMed ID: 3575429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Laser-Doppler flowmetry in the assessment of "mild" Raynaud's phenomenon and its treatment.
    Cesarone MR; Laurora G; Smith SR; Belcaro G
    Panminerva Med; 1990; 32(4):151-4. PubMed ID: 2090987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A plethysmographic study of the effect of tetranicotinoylfructose (Bradilan) on digital blood flow in primary and secondary Raynaud's phenomenon.
    Antcliff AC; Bouhoutsos J; Martin P; Morris T
    Angiology; 1974 May; 25(5):312-6. PubMed ID: 4823806
    [No Abstract]   [Full Text] [Related]  

  • 37. A double blind randomised placebo controlled trial of hexopal in primary Raynaud's disease.
    Sunderland GT; Belch JJ; Sturrock RD; Forbes CD; McKay AJ
    Clin Rheumatol; 1988 Mar; 7(1):46-9. PubMed ID: 3044673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin.
    Shawket S; Dickerson C; Hazleman B; Brown MJ
    Br J Clin Pharmacol; 1991 Aug; 32(2):209-13. PubMed ID: 1931469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome.
    Keenan EJ; Porter JM
    Surgery; 1983 Aug; 94(2):204-9. PubMed ID: 6308842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon?
    Brouwer RM; Wenting GJ; Visser W; Schalekamp MA
    Vasa Suppl; 1987; 18():64-7. PubMed ID: 3299817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.